This study aimed to compare changes in postural control in different testing conditions involving sensory disturbances, quality of life and neurotoxicity concerns in women with cancer before and after chemotherapy with taxanes.
The second aim was to compare postural control between chemotherapy-induced peripheral neuropathy (CIPN) severity subgroups.
